Cell Source, Inc.: 10-Q filed 2020-08-14
What Cell Source, Inc. reported in its quarterly report filed 2020-08-14 (fiscal Q2 2020): 23 published measures, 70 facts as tagged in accession 0001640334-20-002131.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2020-08-14
- Fiscal period
- fiscal Q2 2020
- Accession
- 0001640334-20-002131 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Cell Source, Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-06-30 | 82,293 | USD | |
| At 2019-12-31 | 114,783 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-06-30 | 6,610,310 | USD | |
| At 2019-12-31 | 5,856,724 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-06-30 | -6,528,017 | USD | |
| At 2020-03-31 | -6,257,870 | USD | |
| At 2019-12-31 | -5,741,941 | USD | |
| At 2019-06-30 | -5,153,771 | USD | |
| At 2019-03-31 | -5,111,461 | USD | |
| At 2018-12-31 | -4,920,171 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-06-30 | 1,113 | USD | |
| At 2019-12-31 | 27,908 | USD | |
| At 2019-06-30 | 28,077 | USD | |
| At 2018-12-31 | 18,934 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-04-01 to 2020-06-30 | -1,164,688 | USD | 91 |
| 2020-01-01 to 2020-06-30 | -1,978,435 | USD | 182 |
| 2019-04-01 to 2019-06-30 | -952,985 | USD | 91 |
| 2019-01-01 to 2019-06-30 | -2,411,494 | USD | 181 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-01-01 to 2020-06-30 | -1,153,795 | USD | 182 |
| 2019-01-01 to 2019-06-30 | -1,186,126 | USD | 181 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-01-01 to 2020-06-30 | 1,127,000 | USD | 182 |
| 2019-01-01 to 2019-06-30 | 1,195,269 | USD | 181 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-06-30 | -23,124,263 | USD | |
| At 2019-12-31 | -21,145,828 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-01-01 to 2020-06-30 | 321,397 | USD | 182 |
| 2019-01-01 to 2019-06-30 | 0 | USD | 181 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-04-01 to 2020-06-30 | -903,331 | USD | 91 |
| 2020-01-01 to 2020-06-30 | -1,636,663 | USD | 182 |
| 2019-04-01 to 2019-06-30 | -708,706 | USD | 91 |
| 2019-01-01 to 2019-06-30 | -1,846,561 | USD | 181 |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-04-01 to 2020-06-30 | 81,164 | USD | 91 |
| 2020-01-01 to 2020-06-30 | 157,647 | USD | 182 |
| 2019-04-01 to 2019-06-30 | 65,063 | USD | 91 |
| 2019-01-01 to 2019-06-30 | 150,424 | USD | 181 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-06-30 | 6,610,310 | USD | |
| At 2019-12-31 | 5,711,724 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-06-30 | 445,806 | USD | |
| At 2019-12-31 | 135,415 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-04-01 to 2020-06-30 | 903,331 | USD | 91 |
| 2020-01-01 to 2020-06-30 | 1,636,663 | USD | 182 |
| 2019-04-01 to 2019-06-30 | 708,706 | USD | 91 |
| 2019-01-01 to 2019-06-30 | 1,846,561 | USD | 181 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-04-01 to 2020-06-30 | 159,926 | USD | 91 |
| 2020-01-01 to 2020-06-30 | 417,471 | USD | 182 |
| 2019-04-01 to 2019-06-30 | 385,770 | USD | 91 |
| 2019-01-01 to 2019-06-30 | 1,110,512 | USD | 181 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-06-30 | 29,699,509 | shares | |
| At 2019-12-31 | 27,076,762 | shares |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-06-30 | 946,560 | USD | |
| At 2019-12-31 | 1,063,807 | USD |
Profit or loss including noncontrolling interests
Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-04-01 to 2020-06-30 | -1,164,688 | USD | 91 |
| 2020-01-01 to 2020-03-31 | -813,747 | USD | 91 |
| 2019-04-01 to 2019-06-30 | -952,985 | USD | 91 |
| 2019-01-01 to 2019-03-31 | -1,458,509 | USD | 90 |
Net income available to common stockholders
Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-04-01 to 2020-06-30 | -1,376,573 | USD | 91 |
| 2020-01-01 to 2020-06-30 | -2,401,625 | USD | 182 |
| 2019-04-01 to 2019-06-30 | -1,141,958 | USD | 91 |
| 2019-01-01 to 2019-06-30 | -2,748,502 | USD | 181 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-04-01 to 2020-06-30 | 693,405 | USD | 91 |
| 2020-01-01 to 2020-06-30 | 1,107,525 | USD | 182 |
| 2019-04-01 to 2019-06-30 | 297,936 | USD | 91 |
| 2019-01-01 to 2019-06-30 | 686,049 | USD | 181 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-04-01 to 2020-06-30 | -261,357 | USD | 91 |
| 2020-01-01 to 2020-06-30 | -341,772 | USD | 182 |
| 2019-04-01 to 2019-06-30 | -244,279 | USD | 91 |
| 2019-01-01 to 2019-06-30 | -564,933 | USD | 181 |
Interest paid, net
Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-01-01 to 2020-06-30 | 0 | USD | 182 |
| 2019-01-01 to 2019-06-30 | 0 | USD | 181 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-01-01 to 2020-06-30 | 310,391 | USD | 182 |
| 2019-01-01 to 2019-06-30 | 15,882 | USD | 181 |
Inspect the source
- Entity
- Cell Source, Inc. / CIK 0001569340
- Captured
- SEC response SHA-256
a38ee9440e4c17d7e1a60b5c62fea787c32a17056a875641a758e857a5dd95d2
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001569340.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))